CROX Crocs (CROX) Insider Trading, Ownership & Congress Trades
Materials · Rubber & plastics footwear · CIK 0001334036
Form 144 · 3
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
243
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $1.4M priced
What the filings say about CROX
Insiders, 180 days
-$7.4M net sold
2 buyers · 1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$5.5M
3 notices
Crocs insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Crocs, Inc. insiders sold a net $7.4M of stock across 119 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 16 earlier Form 4 trades (code P or S) here by this insider (12 buys, 4 sales), the last on Sep 10, 2026.
- -17.9% median (-10.1% mean) 90-day return after 8 previous buys.
- The trade is 100.0% of the 680 shares held after it.
- 1 other insider bought within 30 days.
- 243 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SMACH THOMAS J bought about $75.8K of CROX on Sep 15, 2026; 1 other insider bought within 30 days and 243 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 7, 2022.
- The trade is 5.8% of the 15,259 shares held after it.
- 1 other insider bought within 30 days.
- 243 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director KAPLAN BETH J bought about $99.2K of CROX on Sep 15, 2026; 1 other insider bought within 30 days and 243 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (10 buys, 4 sales), the last on Feb 20, 2026.
- -17.9% median (-10.1% mean) 90-day return after 8 previous buys.
- The trade is 0.9% of the 112,063 shares held after it.
- 1 other insider bought within 30 days.
- 243 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SMACH THOMAS J bought about $109.3K of CROX on Sep 10, 2026; 1 other insider bought within 30 days and 243 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (10 buys, 4 sales), the last on Feb 20, 2026.
- -17.9% median (-10.1% mean) 90-day return after 8 previous buys.
- The trade is 3.2% of the 93,249 shares held after it.
- 1 other insider bought within 30 days.
- 243 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SMACH THOMAS J bought about $328.3K of CROX on Sep 10, 2026, the largest insider purchase at the company since 2023; 1 other insider bought within 30 days and 243 funds added in the latest 13F quarter.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 7, 2026.
- The trade is 1.3% of the 722,789 shares held after it.
- No other insider sold within 30 days.
- 243 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Rees Andrew sold about $1.3M of CROX on Aug 10, 2026; 243 funds added in the latest 13F quarter.119 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$7.4M over 180 days
-$3.5M over 90 days
below 92% of Materials
Congress
no House purchase disclosed in the last 12 months
Funds
243 funds bought in last quarter
more than 76% of Materials
Revenue
-1.5% year over year
below 58% of Materials
Margin
-2.0% net margin
below 58% of Materials
Buybacks
$256.2M repurchased, FY to 2026-06-30
more than 91% of Materials
Short interest
10.8% of the float short (float per yahoo 2026-10-26) · 4.0 days to cover · settled 2026-09-30
more than 90% of Materials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CROX
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+39.6%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CROX: institutional holders (13F)
13F holdings, latest reported quarter
4,652,050 sh
$561.2M
3,507,502 sh
$423.1M
2,165,082 sh
$261.2M
2,094,077 sh
$252.6M
1,589,283 sh
$191.7M
Congress trades in CROX
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CROX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
THE REES FAMILY LIVING TRUST
Filed 2026-08-10
$2.6M
THE REES FAMILY LIVING TRUST
Filed 2026-08-07
$1.5M
THE REES FAMILY FOUNDATION, INC
Filed 2026-08-07
$1.4M
CROX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Miller Value Partners Appreciation ETF
$5.0M position · as of 2026-06-30
7.1%
The Acquirers Fund
$1.1M position · as of 2026-07-31
3.3%
Patient Opportunity Trust
$66.4M position · as of 2026-06-30
3.3%
Evercore Equity Fund
$13.9M position · as of 2026-06-30
2.6%
Cromwell Tran Focus Fund
$542.9K position · as of 2026-06-30
2.3%
Euclidean Fundamental Value ETF
$2.9M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Andrew Rees
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$11.0M
$7.4M
$3.4M
+36%
-42%
2024
$12.4M
$14.3M
$4.3M
+75%
-25%
2023
$10.7M
$8.7M
$2.4M
+49%
-13%
2022
$9.9M
-$4.4M
$1.9M
+73%
-13%
2021
$15.8M
$57.4M
$4.8M
+105%
+18%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $7.4M sold by insiders over 180 days, 243 funds added last quarter, $5.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CROX financials
Revenue growth
-1.5%
XBRL, annual
Net margin
-2.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CROX
| FY Dec 2025 | $4.0B |
| FY Dec 2024 | $4.1B |
| FY Dec 2023 | $4.0B |
| FY Dec 2022 | $3.6B |
| FY Dec 2021 | $2.3B |
| Jun 2026 | $1.2B |
| Mar 2026 | $921.5M |
| Dec 2025 | $957.6M |
| Sep 2025 | $996.3M |
| Jun 2025 | $1.1B |
| Mar 2025 | $937.3M |
| Dec 2024 | $989.8M |
| Sep 2024 | $1.1B |
At each fiscal year end
Single quarter
Net margin, TTM
+14.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CROX
| FY Dec 2025 | -2.0% |
| FY Dec 2024 | +23.2% |
| FY Dec 2023 | +20.0% |
| FY Dec 2022 | +15.2% |
| FY Dec 2021 | +31.4% |
| Jun 2026 | +17.4% |
| Mar 2026 | +14.9% |
| Dec 2025 | +11.0% |
| Sep 2025 | +14.6% |
| Jun 2025 | -42.8% |
| Mar 2025 | +17.1% |
| Dec 2024 | +37.3% |
| Sep 2024 | +18.8% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$704.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CROX
| FY Dec 2025 | $659.2M |
| FY Dec 2024 | $923.1M |
| FY Dec 2023 | $814.8M |
| FY Dec 2022 | $499.0M |
| FY Dec 2021 | $511.2M |
| Jun 2026 | $331.0M |
| Mar 2026 | -$98.9M |
| Dec 2025 | $246.4M |
| Sep 2025 | $226.2M |
| Jun 2025 | $269.2M |
| Mar 2025 | -$82.6M |
| Dec 2024 | $303.4M |
| Sep 2024 | $278.8M |
At each fiscal year end
Single quarter
Debt to equity
0.95x
long-term 2026-06-30 plus current 2026-03-31; equity 2026-06-30
Debt to equity CROX
| FY Dec 2025 | 0.95x |
| FY Dec 2024 | 0.74x |
| FY Dec 2023 | 1.14x |
| FY Dec 2022 | 2.84x |
| FY Dec 2021 | 54.78x |
| Jun 2026 | 0.95x |
| Mar 2026 | 0.94x |
| Dec 2025 | 0.95x |
| Sep 2025 | 0.97x |
| Jun 2025 | 0.97x |
| Mar 2025 | 0.75x |
| Dec 2024 | 0.74x |
| Sep 2024 | 0.82x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.58x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-03-31
Cash flow to debt CROX
| FY Dec 2025 | 0.58x |
| FY Dec 2024 | 0.74x |
| FY Dec 2023 | 0.56x |
| FY Dec 2022 | 0.26x |
| FY Dec 2021 | 0.74x |
| Jun 2026 | 0.58x |
| Mar 2026 | 0.52x |
| Dec 2025 | 0.58x |
| Sep 2025 | 0.59x |
| Jun 2025 | 0.61x |
| Mar 2025 | 0.64x |
| Dec 2024 | 0.74x |
| Sep 2024 | 0.72x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+42.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CROX
| FY Dec 2025 | -5.2% |
| FY Dec 2024 | +57.8% |
| FY Dec 2023 | +69.8% |
| FY Dec 2022 | +129.9% |
| FY Dec 2021 | +476.3% |
| Jun 2026 | +42.3% |
| Mar 2026 | -6.1% |
| Dec 2025 | -5.2% |
| Sep 2025 | +11.8% |
| Jun 2025 | +15.4% |
| Mar 2025 | +53.7% |
| Dec 2024 | +57.8% |
| Sep 2024 | +57.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+13.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CROX
| FY Dec 2025 | -1.8% |
| FY Dec 2024 | +20.1% |
| FY Dec 2023 | +17.3% |
| FY Dec 2022 | +17.9% |
| FY Dec 2021 | +54.5% |
| Jun 2026 | +13.5% |
| Mar 2026 | -2.2% |
| Dec 2025 | -1.8% |
| Sep 2025 | +4.1% |
| Jun 2025 | +5.2% |
| Mar 2025 | +19.4% |
| Dec 2024 | +20.1% |
| Sep 2024 | +18.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+26.0%
operating income after a 21.9% effective tax rate, over long-term 2026-06-30 plus current 2026-03-31 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CROX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +35.7% |
| FY Dec 2022 | +25.2% |
| FY Dec 2021 | n/a |
| Jun 2026 | +26.0% |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | +34.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+22.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CROX
| FY Dec 2025 | +4.0% |
| FY Dec 2024 | +25.5% |
| FY Dec 2023 | +26.6% |
| FY Dec 2022 | +33.9% |
| FY Dec 2021 | +68.9% |
| Jun 2026 | +22.8% |
| Mar 2026 | +3.2% |
| Dec 2025 | +4.0% |
| Sep 2025 | +5.3% |
| Jun 2025 | +6.8% |
| Mar 2025 | +23.9% |
| Dec 2024 | +25.5% |
| Sep 2024 | +25.9% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.41x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CROX
| FY Dec 2025 | n/a |
| FY Dec 2024 | 6.89x |
| FY Dec 2023 | 7.30x |
| FY Dec 2022 | 12.48x |
| FY Dec 2021 | 11.26x |
| Jun 2026 | 10.56x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 28.13x |
| Jun 2025 | 27.90x |
| Mar 2025 | 6.55x |
| Dec 2024 | 6.89x |
| Sep 2024 | 10.52x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$6.8B
market value at close 2026-10-26 on 2026-07-23 shares, plus long-term 2026-06-30 plus current 2026-03-31, minus cash 2026-06-30
Enterprise value CROX
| FY Dec 2025 | $5.5B |
| FY Dec 2024 | $7.6B |
| FY Dec 2023 | $7.2B |
| FY Dec 2022 | $8.8B |
| FY Dec 2021 | $8.1B |
| Jun 2026 | $7.1B |
| Mar 2026 | $5.4B |
| Dec 2025 | $5.5B |
| Sep 2025 | $5.7B |
| Jun 2025 | $6.9B |
| Mar 2025 | $7.3B |
| Dec 2024 | $7.6B |
| Sep 2024 | $9.8B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+12.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield CROX
| FY Dec 2025 | +14.8% |
| FY Dec 2024 | +14.5% |
| FY Dec 2023 | +14.4% |
| FY Dec 2022 | +7.5% |
| FY Dec 2021 | +6.8% |
| Jun 2026 | +11.8% |
| Mar 2026 | +15.4% |
| Dec 2025 | +14.8% |
| Sep 2025 | +15.7% |
| Jun 2025 | +13.5% |
| Mar 2025 | +14.8% |
| Dec 2024 | +14.5% |
| Sep 2024 | +10.9% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.05x
P/E over trailing EPS growth of 215%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CROX
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.28x |
| FY Dec 2023 | 0.15x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.08x |
| Jun 2026 | 0.05x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | 0.25x |
| Dec 2024 | 0.28x |
| Sep 2024 | 0.39x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $4.0B | $4.1B | $4.0B | $3.6B |
| Gross profit | $2.4B | $2.4B | $2.2B | $1.9B |
| Operating income | $149.5M | $1.0B | $1.0B | $850.8M |
| Net income | -$81.2M | $950.1M | $792.6M | $540.2M |
| EPS (diluted) | -1.50 | 15.88 | 12.79 | 8.71 |
| Operating cash flow | $710.4M | $992.5M | $930.4M | $603.1M |
| Cash | $130.4M | $180.5M | $149.3M | $191.6M |
| Long-term debt | $1.2B | $1.3B | $1.6B | $2.3B |
| Buybacks | $582.3M | $552.5M | $175.0M | $0 |
SEC XBRL, fiscal years, as known on 2026-10-28
CROX Stock Sonar score 6/7 axes
Find similar shapesCompareCROX ranks highest on profitability (92nd percentile) and institutional and government (76th), and lowest on growth (42nd), among Materials peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CROX filings, in plain words
Are Crocs insiders buying or selling CROX?
In the 180 days to 2026-10-28, Crocs insiders were net sellers, a net $7.4M: $612.6K of purchases and $8.0M of sales reported on Form 4, by 2 buyers and 1 seller.
Are there planned insider sales of CROX?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $5.5M of stock; the latest, by THE REES FAMILY LIVING TRUST, was filed 2026-08-10.
Read the full summary
In the 180 days to 2026-10-28, Crocs insiders were net sellers of CROX, a net $7.4M across purchases and sales reported on Form 4 by 2 buyers and 1 seller. Sales outweighed purchases more than tenfold by value. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. None of the 9 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $5.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
